AS Pro Kapital Grupp (FRA:17E)

Inozyme Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	75	45	60	34	82	40
Market Cap Growth	13.40%	-25.31%	74.09%	-57.92%	105.71%	-49.64%
Enterprise Value	120	86	85	62	134	161
Last Close Price	1.17	0.70	0.91	0.61	1.41	0.67
PE Ratio	3741.40	-	-	2.55	2.74	-
PS Ratio	2.72	2.46	2.60	0.52	1.89	2.91
PB Ratio	1.41	0.87	1.10	0.62	1.91	4.15
P/TBV Ratio	1.52	0.95	1.10	0.63	1.92	3.12
P/FCF Ratio	-	-	7.17	2.12	6.23	-
P/OCF Ratio	-	-	6.58	1.91	6.14	-
EV/Sales Ratio	4.36	4.73	3.68	0.94	3.10	11.82
EV/EBITDA Ratio	30.10	324.33	71.18	5.25	28.56	-
EV/EBIT Ratio	54.78	-	96.17	5.37	30.08	-
EV/FCF Ratio	-16.13	-	10.15	3.82	10.19	-
Debt / Equity Ratio	0.92	0.96	0.81	0.69	1.18	14.09
Debt / EBITDA Ratio	12.23	101.11	33.34	3.22	10.47	-
Debt / FCF Ratio	-	-	5.28	2.37	3.84	-
Asset Turnover	0.24	0.16	0.22	0.60	0.29	0.07
Inventory Turnover	0.39	0.28	0.46	1.06	0.56	0.19
Quick Ratio	0.22	0.14	0.48	1.66	0.40	0.07
Current Ratio	1.90	1.65	1.46	6.97	2.66	0.50
Return on Equity (ROE)	-0.53%	-7.34%	-1.64%	27.41%	129.25%	-8.31%
Return on Assets (ROA)	1.21%	-0.56%	0.53%	6.62%	1.88%	-0.24%
Return on Capital (ROIC)	1.41%	-0.63%	0.57%	7.69%	2.34%	-0.28%
Return on Capital Employed (ROCE)	2.50%	-	1.30%	12.10%	4.90%	-
Earnings Yield	0.03%	-8.23%	-1.50%	39.16%	36.45%	-140.31%
FCF Yield	-9.95%	-23.49%	13.95%	47.14%	16.06%	-19.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.